October 20th, 2026Tezepelumab sustains EoE remission through 52 weeks Tezepelumab produced histologic remission in up to 68.9% of patients aged 12+ with EoE vs 3.5% with placebo at week 24, sustained to week 52.Read more
October 19th, 2026Mirikizumab meets 1-year remission end point in pediatric UCIn phase 3 SHINE-2, 50% of mirikizumab induction responders aged 6 to 17 with moderate to severe UC were in clinical remission at week 52.Read more
October 8th, 2026 Consistency key to managing pediatric constipationAt AAP 2026, Justin Wheeler, MD, discussed bowel cleanouts, maintenance therapy, and behavioral strategies for managing constipation in children.Read more
October 8th, 2026Pediatric constipation: Recognizing red flags and symptomsJustin Wheeler, MD, explains how pediatricians can identify constipation across age groups and distinguish overflow incontinence from diarrhea.Read more
October 5th, 2026Probiotics in pediatrics: Evidence, product quality, and safetyMark R. Corkins, MD, CNSC, FASPEN, AGAF, FAAP, reviews where pediatric probiotic evidence is strongest, why product quality varies, and which children should avoid them. Read more
November 6th, 2026Contemporary Pediatrics week in review: November 2-6, 2026Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.Read more
November 6th, 2026Maternal RSVpreF 78% effective against infant RSV hospitalizationA meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.Read more
November 5th, 2026Skipping newborn vitamin K tied to 47% higher infant bleeding riskIn 5.2 million US infants, newborn vitamin K nonreceipt rose to 6.8% by 2025 and was tied to a 47% higher bleeding risk by 6 months.Read more